Pilanz Adverse Reactions

Undesirable Effects may be founded during treatment with Olanzapine.
Cardiovascular system: orthostatic hypotension, peripheral edema, venous thromboembolic effects, including pulmonary embolism and deep vein thrombosis, QTc prolongation, tachycardia, bradycardia.
Central nervous system: anxiety, dizziness, somnolence, lethargy, abnormal gait, akathisia, dystonia, dyskinesia, tardive dyskinesia, neuroleptic malignant syndrome (NMS), parkinsonism, extrapyramidal syndrome, falling, fatigue, insomnia, tremor, seizure, amnesia, hallucination.
Endocrine and metabolic system: increased serum prolactin, breast changes (including discharge, enlargement, galactorrhea, gynecomastia, lactation disorder) , weight gain, increased appetite, hypercholesterolemia, hypertriglyceridemia, hyperglycemia, diabetic ketoacidosis, diabetic coma, hypothermia, increased body temperature.
Gastrointestinal system: constipation, abdominal distension, nausea, vomiting, dry mouth, pancreatitis.
Genitourinary system: urinary incontinence, urinary retention, urinary hesitation.
Hepatic: Transient, asymptomatic elevations of hepatic aminotransferase, increased serum ALT/SGPT, increased serum AST/SGOT, hepatic injury (cholestatic or mixed), hepatitis, increased total bilirubin, jaundice.
Neuromuscular and skeletal system: arthralgia, rhabdomyolysis.
Skin and cutaneous tissue: alopecia, photosensitivity reaction, erythema.
Hematologic and immunologic system: leukopenia, neutropenia, thrombocytopenia, eosinophilia, anaphylactoid reaction, angioedema, pruritus, urticaria, rash.
Respiratory system: epistaxis, pneumonia.
Miscellaneous: fever, asthenia, priapism, increased creatine phosphokinase, cardiac death.